Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Non-cash Items (2020 - 2024)

HCW Biologics (HCWB) has disclosed Non-cash Items for 5 consecutive years, with $799393.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Non-cash Items fell 15.23% year-over-year to $799393.0, compared with a TTM value of $799393.0 through Dec 2024, down 15.23%, and an annual FY2024 reading of $799393.0, up 235.58% over the prior year.
  • Non-cash Items was $799393.0 for Q4 2024 at HCW Biologics, down from $942998.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $1.1 million in Q4 2021 and bottomed at $39078.0 in Q4 2020.
  • Average Non-cash Items over 5 years is $715512.4, with a median of $799393.0 recorded in 2024.
  • The sharpest move saw Non-cash Items skyrocketed 2776.85% in 2021, then tumbled 40.24% in 2022.
  • Year by year, Non-cash Items stood at $39078.0 in 2020, then surged by 2776.85% to $1.1 million in 2021, then crashed by 40.24% to $671878.0 in 2022, then surged by 40.35% to $942998.0 in 2023, then dropped by 15.23% to $799393.0 in 2024.
  • Business Quant data shows Non-cash Items for HCWB at $799393.0 in Q4 2024, $942998.0 in Q4 2023, and $671878.0 in Q4 2022.